🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

NAEnrolling by InvitationNCT05757960

TMD-specific Physiotherapy in hEDS Patients Individuals With Hypermobile Ehlers-Danlos Syndrome

👨‍⚕️ Ole Oelerich, Dr. med. dent., Department for Prosthodonctics and Biomaterials, University Hospital Münster📍 1 site📅 Started Feb 2023View details ↗
Phase 1, PHASE2RecruitingNCT05747261

Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)

👨‍⚕️ Arina V Zinkina-Orikhan, PhD, Director of Clinical Development Department, BIOCAD📍 7 sites📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05492682

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

🏥 Valo Therapeutics Oy📍 3 sites📅 Started Feb 2023View details ↗
NARecruitingNCT05538910

Defining Neurobiological Links Between Substance Use and Mental Illness

👨‍⚕️ Amy C Janes, Ph.D., National Institute on Drug Abuse (NIDA)📍 1 site📅 Started Feb 2023View details ↗
EARLY_Phase 1RecruitingNCT05874310

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

👨‍⚕️ Gezhi Xu, Eye & ENT Hospital of Fudan University📍 2 sites📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05684731

Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer

👨‍⚕️ Qinglei Gao, MD. PhD, Tongji Hospital📍 1 site📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05464368

R21 Roche: 3-Way Tau Tracers in AD

👨‍⚕️ Dean F Wong, Head Researcher/Professor of Radiology📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05713877

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

👨‍⚕️ François Marquis, M.D., M.A., Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Est-de-l'Île-de-Montréal📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT06585722

Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population

🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT03989778

Vitamin D and Polycystic Ovarian Syndrome (PCOS)

🏥 Aga Khan University📍 2 sites📅 Started Feb 2023View details ↗
NARecruitingNCT06711952

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

👨‍⚕️ Robert Perneczky, Prof. Dr., Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05748717

Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease

🏥 The University of The West Indies📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05785793

Autoimmune Hepatitis Cohort in China

👨‍⚕️ Xiong Ma, MD,PHD, Renji Hospital, School of Medicine, Shanghai Jiao Tong University📍 1 site📅 Started Feb 2023View details ↗
Phase 1Enrolling by InvitationNCT05301361

Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

🏥 University of California, Davis📍 3 sites📅 Started Feb 2023View details ↗
RecruitingNCT05745961

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

👨‍⚕️ Martin Wilkins, Imperial College London📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05711992

Rare Embryonal Tumors of the Central Nervous System: International Registry

👨‍⚕️ Julieta Hoveyan, MD, Immune Oncology Research Institute, Yerevan, Armenia📍 11 sites📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05327686

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

👨‍⚕️ William A Hall, NRG Oncology📍 318 sites📅 Started Feb 2023View details ↗
NARecruitingNCT05751733

Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST

🏥 Xiangya Hospital of Central South University📍 1 site📅 Started Feb 2023View details ↗
NARecruitingNCT05738980

Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3

👨‍⚕️ Jie Ma, Doctor, Beijing Hospital📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT05728957

Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

👨‍⚕️ Hiten D Patel, MD, MPH, Loyola University📍 1 site📅 Started Feb 2023View details ↗
← PreviousPage 430 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →